Psychedelic Treatment Research Clinical Trial Award (DOD)
Federal Grants & Contracts August 30, 2024 Peer reviewed DOI: 10.1002/fgc.33899 via OpenAlex
Abstract
No abstract available from the source.
Related reading
- Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidence Psychedelics. • October 28, 2025 • via OpenAlex
- 229. PSILOCYBIN WITH PSYCHOTHERAPEUTIC SUPPORT FOR TREATMENT-RESISTANT DEPRESSION: A PILOT CLINICAL TRIAL The International Journal of Neuropsychopharmacology • August 1, 2025 • via OpenAlex
- 188. Mapping Psilocybin Therapy: A Systematic Review of Therapeutic Frameworks, Adaptations, and Standardization Across Contemporary Clinical Trials Biological Psychiatry • April 9, 2025 • via OpenAlex
- Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis BMJ • August 21, 2024 • via OpenAlex
- Acute Adverse Effects of Therapeutic Doses of Psilocybin JAMA Network Open • April 10, 2024 • via OpenAlex